期刊文献+

脂联素/高敏C-反应蛋白比值对冠心病严重程度的预测价值

Predictive value of adiponectin/high sensitivity C-reaction protein ratio on coronary artery diseases severity
下载PDF
导出
摘要 目的:评估脂联素/高敏C-反应蛋白比值对冠心病严重程度的预测价值。方法:收集78例确诊为冠心病的患者,将其分为稳定型心绞痛组、急性冠脉综合征组及ST段抬高型心肌梗死组3组,检测空腹静脉血浆高敏C-反应蛋白及脂联素水平,并计算脂联素/C-反应蛋白比值,分析冠心病患者血浆脂联素/C-反应蛋白比值与冠心病严重程度的相关性。同时收集30例健康者作为对照组。结果:冠心病患者血浆高敏C-反应蛋白水平均明显高于对照组(P<0.05),但急性冠脉综合征及ST段抬高型心肌梗死组间无差别;急性冠脉综合征及ST段抬高型心肌梗死组APN水平均明显低于对照组(P<0.05),稳定型心绞痛组与对照组无差别;脂联素/C-反应蛋白比值随冠心病严重程度逐渐增加而减低(P<0.05)。spearman等级相关分析提示脂联素/C-反应蛋白比值与冠心病严重程度相关性最大,r=-0.978。结论:血浆脂联素/C-反应蛋白比值对冠心病严重程度具有较好的预测价值。 Objective: To investigate the predictive value of adiponectin (APN)/High sensitivity C-reaction protein (Hs-CRP) ratio on coronary artery diseases severity. Methods: 78 patients with coronary artery diseases were divided into stable angina, acute coronary syndrome and ST elevation myocardial infarction groups.Fasting venous blood was used to detect Hs-CRP and APN level.APN/Hs-CRP ratio was calculated and used to evaluate the relationship between the APN/Hs-CRP ratio and coronary artery diseases severity. We also enrolled 30 healthy participants as a control group. Results: Hs-CRP level in coronary artery disease groups were significant higher than control group (P0.05) but there was no difference between ACS and STEMI groups. APN level was significant lower in ACS and STEMI groups (P0.05)whereas there was no difference between SA and control group.APN/Hs-CRP ratio gradually decreases accompanying with the increased severity of coronary artery diseases.The relationship between APN/Hs-CRP ratio and coronary artery diseases severity was strongest (r=-0.978) indicating by spearman analysied. Conclusion: Serum APN/Hs-CRP ratio has a well predictive value on coronary artery diseases severity.
作者 黄存敏
出处 《中国当代医药》 2010年第20期79-80,共2页 China Modern Medicine
关键词 脂联素 高敏C-反应蛋白 冠心病 Adiponectin High sensitivity C-reaction protein Coronary artery diseases
  • 相关文献

参考文献6

  • 1Bajpai A,Goyal A,Sperling L.Should we measure C-reactive protein on earth or just on JUPITER[J].Clin Cardiol,2010,33(4):190-198.
  • 2Kai T,Arima S,Taniyama Y,et al.Comparison of the effect of lipophilic and hydrophilic statins on serum adiponectin levels in patients with mild hypertension and dyslipidemia:Kinki Adiponeetin Interventional (KAI)Study[J].Clin Exp Hypertens,2008,30(7):530-540.
  • 3Blake GJ,Rifai N,Buring JE,et al.Blood pressure,C-reactive protein,and risk of future cardiovascular events[J].Circulation,2003,108(24):2993-2999.
  • 4张建秋,柳尧学,王其瑞.高血压病患者血压变异性与高敏C反应蛋白关联性研究的临床分析[J].中国医药导报,2008,5(3):56-57. 被引量:3
  • 5M van der Meet IM,M de Maat MP,Bots ML,et al.Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis:the Rotterdam Study[J].Arterioscler Thromb Vasc Biol,2002,22(5):838-842.
  • 6Blaneo-Colio LM,Martin-Ventura JL,Gomez-Guerrero C,et al.Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk[J].Eur J Pharmacol,2008,586(1-3):259-265.

二级参考文献3

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部